Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
M007 is a synthetic polymer-based hydrogel developed by Pleryon Therapeutics for applications in regenerative medicine and aesthetics. Developed using a proprietary platform that controls the 2D sequence and 3D structure of extra-large polymeric molecules, M007 is designed to mimic the properties of natural biomolecules like lubricin. It functions primarily through physical and mechanical means, providing a structural scaffold to facilitate tissue repair and regeneration. While positioned as a state-of-the-art regenerative injectable, specific molecular targets and clinical development phases for M007 have not been publicly disclosed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on M007.